secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001367644-25-000114
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions stockholders elect three Class I directors, ratify auditor, approve advisory compensation
--------------------------------------------------------------------------------

- Annual meeting held April 30, 2025; 36,140,808 shares (67% of outstanding) present.
- Class I directors Keith Katkin, Ronald Richard, Kathryn Zoon each elected with >18M votes for.
- Ernst & Young ratified as independent auditor for FY2025 with 34,773,959 for, 1,152,704 against.
- Advisory vote on named executive officer compensation approved with 18,928,777 for, 3,537,501 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000136764425000114/0001367644-25-000114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000136764425000114/ebs-20250430.htm
  HTML page:      https://secwatch.observer/filing/0001367644-25-000114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer